ewsba.se
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades:
Wells Fargo upgraded United Therapeutics (UTHR) to Overweight from Equal Weight with a price target of $735, up from $575. The firm says Ralinepag DPI brings confidence in United Therapeutics' competitive position in pulmonary indications over the long term.
JPMorgan upgraded Freshpet (FRPT) to Overweight from Neutral with a price target of $68, up from $66. The firm expects Freshpet's sales and EBITDA growth to outpace its staples peers, and does not think the stock's current valuation sufficiently reflects this.
Arete upgraded Oracle (ORCL) to Buy from Neutral with a $255 price target. The firm says supply constraints are helpful to the economics of graphics processing units.
Barclays upgraded SiTime (SITM) to Overweight from Equal Weight with a price target of $850, up from $400, following the Q1 report. The company's outlook suggests its 2026 revenue will grow over 80% as content increases at existing customers and new opportunities in inferencing drive better visibility and growth, the firm tells investors in a research note.
BTIG upgraded Fortinet (FTNT) to Buy from Neutral with a $125 price target after the company reported "outstanding" Q1 results and gave an updated FY26 outlook that was "materially better than expected."
Guggenheim downgraded Portillo's (PTLO) to Neutral from Buy without a price target. The firm believes the company's search for a new growth design that generates the return on equity to support accelerated development will take time to play out. :the
William Blair downgraded Planet Fitness (PLNT) to Market Perform from Outperform. Both internal and external factors led to a slower member sign-up period during the "seasonally important" first quarter and the company decided to pause its Black Card price hike planned for this summer, pending a broader review, the firm tells investors.
DA Davidson downgraded Clear Secure (YOU) to Neutral from Buy with a price target of $60, down from $65. The firm sees a more balanced risk/reward following the Q1 report.
Jefferies downgraded QuidelOrtho (QDEL) to Hold from Buy with a price target of $12.50, down from $35. The company reported a "disappointing" Q1 and provided a 2026 outlook that relies on a broad second half of the year inflection across China, Middle East, and respiratory, the firm tells investors in a research note.
KeyBanc downgraded Angi Inc. (ANGI) to Sector Weight from Overweight with no price target following Q1 results. With the company no longer providing quarterly guidance, the firm sees visibility into the timing of a return to revenue growth as "diminished" and notes that Angi "materially reduced" its 2026 profitability outlook.
Northland initiated coverage of Surf Air Mobility (SRFM) with an Outperform rating and $5 price target. Surf operates one of the largest regional commuter airlines and management "had the foresight to realize data from the operations was unique and could fuel the creation of the first aviation operating system for regional aviation," the firm tells investors.
Oppenheimer initiated coverage of Aprea Therapeutics (APRE) with an Outperform rating and $5 price target. The firm cites the potential of the company's WEE1 inhibitor APR-1051 and the stock's "sizable valuation discount" relative to peers for the Buy rating.
Bernstein initiated coverage of CNH Industrial (CNH) with a Market Perform rating and $11 price target. The agriculture equipment market is at the bottom, and the direction of travel is up but with no clear catalyst, the firm tells investors in a research note.
Citi initiated coverage of Innovex (INVX) with a Buy rating and $35 price target. The is positive on the company's less cyclicality and "robust" free cash flow conversion relative to its oilfield service peers.
Freedom Broker initiated coverage of Abacus Global (ABX) with a Buy rating and $13 price target. An aging U.S. population, combined with elevated equity market volatility and economic uncertainty, creates opportunities for life insurance policy monetization, the firm tells investors.